Golden Bridge International (GBI), Inc. was founded, in 1993, for the purpose of supplying well-developed, affordable and unique biomedical reagents to research and diagnostic communities, biotech and pharmaceutical industries in Asian countries. The products provided by GBI include neonatal and prenatal screening, Immunohistochemistry (IHC),  molecule biology, and other research products for cancer, hormones, and infectious diseases.

Partnering with many biotech industrial leaders and experts, GBI has been growing with the Asian market. By providing its customers with the excellent products and high quality service and acting as a educator, trainer and marketer, GBI now is the leading company in Chinese neonatal screening and IHC market.  There have been more than 10 millions of Chinese babies being screened with GBI products and there are more than 30% of pathology labs in China using the products supplied by GBI.

Our mission is to bring state-of-art technology and products to researchers and doctors through un-compromised product excellence and knowledgeable technical support